Effects of 5-diazoimidazole-4-carboxamide and 3-diazopyrazole-4-carboxamide and related thioazo compounds on xanthine oxidase, uricase, and hypoxanthine-guanine phosphoriboxyltransferase.
D000493:Allopurinol / Q000494:pharmacology; D000577:Amides / Q000494:pharmacology*; D000818:Animals; D001386:Azides / Q000494:pharmacology; D001391:Azo Compounds / Q000494:pharmacology*; D002110:Caffeine / Q000494:pharmacology; D002417:Cattle; D003979:Diazonium Compounds / Q000494:pharmacology*; D007093:Imidazoles / Q000494:pharmacology*; D007292:Inosine Nucleotides; D015122:Mercaptopurine / Q000494:pharmacology; D010428:Pentosephosphates; D010430:Pentosyltransferases / Q000037:antagonists & inhibitors*; D011720:Pyrazoles / Q000494:pharmacology*; D051381:Rats; D013329:Structure-Activity Relationship; D014226:Triazenes / Q000494:pharmacology; D014503:Urate Oxidase / Q000037:antagonists & inhibitors*; D014969:Xanthine Oxidase / Q000037:antagonists & inhibitors*
D000577:Amides; D001386:Azides; D001391:Azo Compounds; D003979:Diazonium Compounds; D007093:Imidazoles; D007292:Inosine Nucleotides; D010428:Pentosephosphates; D011720:Pyrazoles; D014226:Triazenes; C002568:3-diazopyrazole-4-carboxamide; D002110:Caffeine; D000493:Allopurinol; D015122:Mercaptopurine; D014969:Xanthine Oxidase; D014503:Urate Oxidase; D010430:Pentosyltransferases; C000618831:5-diazoimidazole-4-carboxamide